These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 2109714)
1. Transplantation analysis of B cell destruction in (NOD x CBA)F1 mouse bone marrow chimeras. Serreze DV; Leiter EH; Shultz LD Diabetologia; 1990 Feb; 33(2):84-92. PubMed ID: 2109714 [TBL] [Abstract][Full Text] [Related]
2. Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hemopoietic origin, but not on thymic epithelium. Serreze DV; Leiter EH J Immunol; 1991 Aug; 147(4):1222-9. PubMed ID: 1869820 [TBL] [Abstract][Full Text] [Related]
3. MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice. Leiter EH; Christianson GJ; Serreze DV; Ting AT; Worthen SM J Exp Med; 1989 Oct; 170(4):1243-62. PubMed ID: 2507727 [TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo. Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161 [TBL] [Abstract][Full Text] [Related]
5. Unusual resistance of ALR/Lt mouse beta cells to autoimmune destruction: role for beta cell-expressed resistance determinants. Mathews CE; Graser RT; Savinov A; Serreze DV; Leiter EH Proc Natl Acad Sci U S A; 2001 Jan; 98(1):235-40. PubMed ID: 11136257 [TBL] [Abstract][Full Text] [Related]
7. Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in nonobese diabetic mice. Li H; Kaufman CL; Ildstad ST Surgery; 1995 Aug; 118(2):192-7; discussion 197-8. PubMed ID: 7638733 [TBL] [Abstract][Full Text] [Related]
8. Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Haskins K; Portas M; Bergman B; Lafferty K; Bradley B Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8000-4. PubMed ID: 2510155 [TBL] [Abstract][Full Text] [Related]
9. Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts. Li H; Colson YL; Ildstad ST Transplantation; 1995 Sep; 60(6):523-9. PubMed ID: 7570945 [TBL] [Abstract][Full Text] [Related]
10. Analyses of development of insulitogenic T lymphocytes in NOD mice by transplantation of bone marrow, thymus, and pancreas. Ida T; Yasumizu R; Ohnishi Y; Honxue F; Oyaizu N; Than S; Sugiura K; Inaba MM; Kuzuya H; Makino S Transplantation; 1990 May; 49(5):976-82. PubMed ID: 2186525 [TBL] [Abstract][Full Text] [Related]
11. Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow. Kaufman CL; Li H; Ildstad ST J Immunol; 1997 Mar; 158(5):2435-42. PubMed ID: 9036994 [TBL] [Abstract][Full Text] [Related]
12. Reciprocal allogeneic bone marrow transplantation between NOD mice and diabetes-nonsusceptible mice associated with transfer and prevention of autoimmune diabetes. LaFace DM; Peck AB Diabetes; 1989 Jul; 38(7):894-901. PubMed ID: 2661286 [TBL] [Abstract][Full Text] [Related]
13. Development of either split tolerance or robust tolerance along with humoral tolerance to donor and third-party alloantigens in nonmyeloablative mixed chimeras. Chan WF; Razavy H; Luo B; Shapiro AM; Anderson CC J Immunol; 2008 Apr; 180(8):5177-86. PubMed ID: 18390699 [TBL] [Abstract][Full Text] [Related]
14. Expression of genetically determined diabetes and insulitis in the nonobese diabetic (NOD) mouse at the level of bone marrow-derived cells. Transfer of diabetes and insulitis to nondiabetic (NOD X B10) F1 mice with bone marrow cells from NOD mice. Wicker LS; Miller BJ; Chai A; Terada M; Mullen Y J Exp Med; 1988 Jun; 167(6):1801-10. PubMed ID: 3290380 [TBL] [Abstract][Full Text] [Related]
15. Inducing tolerance to MHC-matched allogeneic islet grafts in diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy. Wu T; Levay-Young B; Heuss N; Sozen H; Kirchhof N; Sutherland DE; Hering B; Guo Z Transplantation; 2002 Jul; 74(1):22-7. PubMed ID: 12134094 [TBL] [Abstract][Full Text] [Related]
16. Islet destruction by the NOD mouse may be mediated by both MHC-restricted and nonrestricted mechanisms. Matsuo S; Mullen Y; Wicker LS; Peterson LB; Nagata M Transplant Proc; 1991 Feb; 23(1 Pt 1):743-4. PubMed ID: 1990674 [No Abstract] [Full Text] [Related]
17. In vivo activity of an islet-reactive T-cell clone. Bradley BJ; Wang YY; Lafferty KJ; Haskins K J Autoimmun; 1990 Aug; 3(4):449-56. PubMed ID: 1977404 [TBL] [Abstract][Full Text] [Related]
18. Induction of stable chimerism and transplantation tolerance to rat islet and heart allografts by ultraviolet-B modulation of bone marrow cells. Jin MX; Engelstad K; Oluwole SF Transplantation; 1992 Jul; 54(1):113-8. PubMed ID: 1385914 [TBL] [Abstract][Full Text] [Related]
19. Effect of H-2 compatibility in autoimmune destruction of islet allografts from B10 congenic lines to nonobese diabetic mice. Clare-Salzler M; Mullen Y; Chai A; Stein E; Girman D; Lennartz K Pancreas; 1994 Mar; 9(2):179-85. PubMed ID: 8190719 [TBL] [Abstract][Full Text] [Related]
20. Specific destruction of islet transplants in NOD<-->C57BL/6 and NOD<-->C3H/Tif embryo aggregation chimeras irrespective of allelic differences in beta-cell antigens. Leijon K; Hillörn V; Bergqvist I; Holmberg D J Autoimmun; 1995 Jun; 8(3):347-56. PubMed ID: 7575996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]